bioengineer.org /6 days ago

Engineered Adeno-Associated Virus Enables Efficient In Vivo Immune Cell Programming

A directed-evolution adeno-associated virus capsid targeting CD7 achieves robust gene delivery and therapeutic chimeric antigen receptor cell engineering in living animal models.

Read source
seekingalpha.com /1 week ago

Acrivon Therapeutics, Inc. (ACRV) Discusses ACR-525 Acquisition and PKC Inhibitor Preclinical Program - Slideshow

Read source
genengnews.com /3 weeks ago

Building the Future of AAV Gene Therapy

This eBook brings together perspectives from across the AAV development and manufacturing continuum. It explores how early commercial planning can help avoid costly delays, how sta...

Read source
seekingalpha.com /2 weeks ago

Annexon, Inc. (ANNX) Discusses Vonaprument Phase III ARCHER II Trial in Geographic Atrophy - Slideshow

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.